Literature DB >> 421182

Atypical lipoma, atypical intramuscular lipoma, and well differentiated retroperitoneal liposarcoma: a reappraisal of 30 cases formerly classified as well differentiated liposarcoma.

H L Evans, E H Soule, R K Winkelmann.   

Abstract

Thirty cases formerly diagnosed as Grade I lipogenic liposarcoma (well differentiated liposarcoma) were reviewed. The basic histologic pattern in all was that of adult fat modified by the presence of cells with enlarged, hyperchromatic nuclei; in most cases there was also a component of myxoid and/or fibrous tissue. The length of follow-up ranged from two to 30 years. Nine of the tumors were located in the subcutaneous layer. None of these recurred after excision, not even those which were simply "shelled out," and none metastasized. The term "atypical lipoma" is proposed for this group. Thirteen were located within or between muscles of the limbs, limb girdles, and head and neck. Nine of these recurred at least one, but there were no metastases and no deaths due to tumor. These were designated "atypical intramuscular lipoma." The remaining eight originated in the retroperitoneum. Although none of these patients developed metastases, five suffered inoperable recurrence and three died as a result of the neoplasm. It is suggested that the term "well differentiated retroperitoneal liposarcoma" be retained for cases of this type.

Entities:  

Mesh:

Year:  1979        PMID: 421182     DOI: 10.1002/1097-0142(197902)43:2<574::aid-cncr2820430226>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  49 in total

1.  Case report 751: Spindle cell lipoma causing marked bone erosion.

Authors:  I J Braunschweig; I H Stein; M I Dodwad; A F Rangwala; A Lopano
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

2.  Case report 637. Mixed type liposarcoma with myxoid and pleomorphic patterns.

Authors:  M H Klein; P Desai
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

Review 3.  Soft-tissue masses in the shoulder girdle: an imaging perspective.

Authors:  Srinivasan Harish; Asif Saifuddin; Philip W P Bearcroft
Journal:  Eur Radiol       Date:  2006-04-25       Impact factor: 5.315

4.  Liposarcoma in a colonic polyp: case report and review of the literature.

Authors:  Rassa Shahidzadeh; Carlos R Ponce; Jeffrey R Lee; Sherman M Chamberlain
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

5.  Liposarcoma of soft tissue: MRI findings with pathologic correlation.

Authors:  R Arkun; A Memis; T Akalin; E E Ustun; D Sabah; G Kandiloglu
Journal:  Skeletal Radiol       Date:  1997-03       Impact factor: 2.199

6.  The degree of sclerosis is associated with prognosis in well-differentiated liposarcoma of the retroperitoneum.

Authors:  John S A Chrisinger; Tariq Al-Zaid; Emily Z Keung; Cheuk Leung; Heather Y Lin; Christina L Roland; Keila E Torres; Robert S Benjamin; Davis R Ingram; Samia Khan; Neeta Somaiah; Behrang Amini; Barry W Feig; Alexander J Lazar; Wei-Lien Wang
Journal:  J Surg Oncol       Date:  2019-06-17       Impact factor: 3.454

Review 7.  [Modern morphological diagnosis and current classification of soft tissue sarcomas].

Authors:  D Katenkamp; K Katenkamp
Journal:  Chirurg       Date:  2009-03       Impact factor: 0.955

8.  Predictive value of gadolinium enhancement in differentiating ALT/WD liposarcomas from benign fatty tumors.

Authors:  M J Panzarella; A H Naqvi; H E Cohen; T A Damron
Journal:  Skeletal Radiol       Date:  2005-03-02       Impact factor: 2.199

9.  Intraoperative Raman spectroscopy of soft tissue sarcomas.

Authors:  John Q Nguyen; Zain S Gowani; Maggie O'Connor; Isaac J Pence; The-Quyen Nguyen; Ginger E Holt; Herbert S Schwartz; Jennifer L Halpern; Anita Mahadevan-Jansen
Journal:  Lasers Surg Med       Date:  2016-07-25       Impact factor: 4.025

10.  Predicting dedifferentiation in liposarcoma: a proteomic approach.

Authors:  Colt M McClain; David B Friedman; Tahar Hajri; Cheryl M Coffin; Justin M M Cates
Journal:  Virchows Arch       Date:  2013-05-26       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.